October 7th, 2013
12:44 PM ET
Since 1999, sales of prescription painkillers in the United States have quadrupled. So have the number of fatal poisonings due to prescription painkillers, according to the National Center for Injury Prevention and Control. Prescription drug misuse is now responsible for more deaths than heroin and cocaine combined.
Despite these shocking statistics, a new report from Trust for America's Health finds many states are lacking effective strategies to curb prescription drug abuse.
The report, titled "Prescription Drug Abuse: Strategies to Stop the Epidemic," shows more than half the states scored a six or less on the advocacy organization's scale, which assesses the ways states are trying to combat prescription drug abuse. Only two states, New Mexico and Vermont, scored 10 out of 10.
"In the past two decades we've seen many advances in the development of new prescription drugs, which have been a miracle for many," said Jeff Levi, executive director of Trust for America's Health. "But we've also seen a corresponding rise in misuse, and the consequences can be dire."
December 14th, 2012
11:21 AM ET
The White House Office of National Drug Control Policy recently sent an alert to law enforcement, particularly along the Canadian border, warning them that Canada had approved non-abuse resistant generic versions of oxycodone, the active ingredient in OxyContin, Percocet and about 40 other painkillers.
"ONDCP expects companies will begin offering these generics without the abuse-resistant features in Canadian pharmacies within the next month," according to the alert.
The letter warned of the potential for these generics to show up here in the United States, where they are no longer available.
December 4th, 2012
01:08 PM ET
CNN recently published a three-day series on the experimental use of the drug Ecstasy as part of treatment for post-traumatic stress disorder. Readers had a lot to say in response to scientists who are studying the effects of MDMA, the chemical name for pure Ecstasy, on patients with PTSD.
Many readers said they were familiar with past research that’s been done on these drugs and questioned why they are still illegal.
September 28th, 2012
12:16 PM ET
Buyers beware when it comes to buying medicine online, the Food and Drug Administration is warning consumers. On Friday, the agency launched "BeSafeRx: Know Your Online Pharmacy," a national campaign to raise awareness about fake Internet pharmacies and their potential risk to consumer health.
“Buying medicines from rogue online pharmacies can be risky because they may sell fake, expired, contaminated, not approved by FDA, or otherwise unsafe products that are dangerous to patients,” said FDA Commissioner Dr. Margaret Hamburg. “Fraudulent and illegal online pharmacies often offer deeply discounted products. If the low prices seem too good to be true, they probably are. FDA’s BeSafeRx campaign is designed to help patients learn how to avoid these risks.”
September 28th, 2012
11:07 AM ET
Do a quick inventory of your medicine cabinet. How many unused prescription pills are hanging out there? If you are like many Americans, your answer is probably:
"Twenty hydrocodone left over from getting my wisdom teeth pulled last year," or
"Fifteen oxycodone left over from the C-section when my son was born."
An estimated 200 million pounds of unused prescriptions are gathering dust in American medicine cabinets, according to the National Community Pharmacists Association. The problem is, those innocuous-seeming leftovers can end up in the wrong hands and, in extreme cases, lead to an overdose.
September 11th, 2012
02:18 PM ET
The Food and Drug Administration has a new cutting-edge tool in its counterfeit drug detection toolbox.
At a symposium Monday, the agency unveiled the Counterfeit Detection Device #3 or CD3, a hand-held device developed by FDA scientists that can be used in the field to detect counterfeit products and packaging.
"This device was designed in-house by FDA scientists in response to the needs for screening in the field," said FDA Commissioner Dr. Margaret Hamburg. "It is low cost compared to other analytical devices, operates with batteries, and requires minimal training to use. It allows for 'real time' comparisons with authentic drugs - and has already proven useful for identifying counterfeit drugs at our busy international mail facilities."
July 25th, 2012
06:05 PM ET
The Senate Commerce Committee bashed drug distributors for up-charging patients at a hearing Wednesday about the “grey-market” for short-supply drugs.
The “grey market” is the second-hand market, where drugs, frequently in short supply, are re-distributed and sold by various distributors and wholesalers.
It’s an already dire situation for many patients in need. According to the U.S. Food and Drug Administration, drug shortages have increased nearly 300% since 2005. Many of the drugs on this list are cancer treatments. The “grey market” only exacerbates the price and the shortage issue.
July 3rd, 2012
04:22 PM ET
The maker of the prescription painkiller OxyContin confirms that a clinical trial is currently underway to measure the opioid's effects in children.
Although doctors can prescribe OxyContin off-label to pediatric patients, the drug - which was overwhelmingly tested in adults – is not approved for use in children by the Food and Drug Administration, and Purdue Pharma says it is not seeking that approval.
To qualify for the study, patients must be between the ages of 6 and 17, have moderate to severe pain, and have already demonstrated a tolerance to opioid painkillers. The study will include 154 children.
July 3rd, 2012
02:44 PM ET
If you are not grappling with cancer-related pain, you probably should not be taking prescription methadone.
That is the message spiraling out of startling statistics suggesting using methadone inappropriately is linked to one-third of prescription painkiller overdose deaths.
Methadone accounted for a mere 2% of prescriptions in 2009, according to Centers for Disease Control and Prevention data that spans 10 years and 13 states, but was responsible for 30% of prescription painkiller deaths.
"Methadone is riskier than other opiates for treating non-cancer pain," said Dr. Thomas Frieden, director of the CDC, who added that there is limited scientific evidence it works for chronic non-cancer pain. "It should only be used for pain when other drugs haven't been effective."
April 19th, 2012
07:35 AM ET
The short-lived high teenagers get from using amphetamines or the club drug MDMA - better known as Ecstasy - could lead to longer-lasting depression later on, a new study suggests.
Researchers in Canada interviewed 3,880 teenagers from low-income neighborhoods in Québec. Compared to their peers who used neither drug, teens who reported taking MDMA or amphetamines at least once in the tenth grade had 70% and 60% higher odds, respectively, of experiencing depression symptoms in the eleventh grade.
Using both drugs nearly doubled the odds of depression.
About this blog
Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.